<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>MOLECULAR CELLULAR BIOLOGY, Feb. 1996, p. 669&#226;&#8364;&#8220;676                                                                              Vol. 16,  2 <br /> 0270-7306/96/$04.0010 <br /> Copyright q 1996, American Society Microbiology <br />  <br />  <br />  <br />                        Paf1p, RNA Polymerase II-Associated Factor <br />                          Saccharomyces cerevisiae,                          Positive Negative Roles Transcription <br />                     XIAOMING SHI,1 ANN FINKELSTEIN,2 ALEXANDER J. WOLF,1 PAUL  WADE,1 <br />                               ZACHARY F. BURTON,2 JUDITH  JAEHNING1* <br />                           Department Biochemistry, Biophysics Genetics, University Colorado Health <br />                              Sciences Center, Denver, Colorado 80262,1 Department Biochemistry, <br />                                       Michigan State University, East Lansing, Michigan 488242 <br />                          Received 22 June 1995/Returned modification 25 July 1995/Accepted 21 November 1995 <br />  <br />              Regulated transcription initiation requires, addition RNA polymerase II general transcription <br />           factors, accessory factors termed mediators adapters. used affinity chromatography identify           collection factors associate Saccharomyces cerevisiae RNA polymerase II (P.  Wade, W. Werel, <br />           R. C. Fentzke, N. E. Thompson, J. F. Leykam, R. R. Burgess, J.  Jaehning,  F. Burton, submitted           publication). report identification characterization gene encoding factors, PAF1 <br />            RNA polymerase-associated factor 1). PAF1 encodes novel, highly charged protein 445 amino acids. <br />           Disruption PAF1 S. cerevisiae leads pleiotropic phenotypic traits, including slow growth, temperature <br />           sensitivity, abnormal cell morphology. Consistent possible role transcription, Paf1p localized <br />           nucleus. comparing abundances yeast transcripts isogenic wild-type paf1 mutant <br />           strains, identified genes expression affected PAF1. particular, disruption PAF1 <br />           decreases induction galactose-regulated genes  fivefold. contrast, transcript level           MAK16, essential gene involved cell cycle regulation, greatly increased paf1 mutant strain. Paf1p <br />           required positive negative regulation subsets yeast genes. Like Paf1p,           GAL11 gene product associated RNA polymerase II required regulated expression           yeast genes including controlled galactose. gal11 paf1 double mutant           severe growth defect single mutants, indicating proteins           function parallel pathways communicate signals regulatory factors RNA polymerase II. <br />  <br />  <br />    Promoter-specific transcription initiation protein-cod-                unidentified polypeptides (32, 33). SRB genes ini- <br /> ing genes eukaryotic systems requires concerted action                  tially identified virtue ability suppress cold- complex array factors, including general factors                   sensitive phenotypes conferred truncation mutations (TFIIA, -B, -E, -F, -H TBP) RNA polymerase II                      RNA polymerase II CTD (40). SRB genes essential <br />  reviews, references 11 72). factors                     normal growth yeast cells, suggesting importance sufficient basal transcription vitro. Transcription initia-             transcriptional regulation (33). Previous biochemical ge- <br /> tion subject regulation promoter-specific activators             netic evidence implicates GAL11 SUG1 transcrip- repressors (57). vitro studies using reconstituted sys-                 tional coactivators (17, 24, 39, 46, 53, 54). class tems revealed additional class factors, coacti-                accessory factors represented yeast SWI-SNF com- <br /> vators adapters, required mediate communication                      plex, affects transcription counteracting repressive promoter-specific regulatory factors general                   effects imposed chromatin structure (41, 67). <br /> transcription machinery (8, 32, 33).                                              identify additional factors interact RNA poly- <br />    Transcriptional coactivators divided sub-               merase II, used monoclonal antibody directed classes, probably corresponding different pathways com-                  RNA polymerase II CTD immobilize enzyme asso- <br /> munication regulatory factors general ma-                      ciated factors transcriptionally active yeast cell <br /> chinery. TFIID complex, mediates signals                        extract (60). collection factors eluted immo- activators, consists TBP TBP-associated factors                    bilized RNA polymerase included TFIIB, TFIIS, (8). Individual TBP-associated factors shown                      subunits TFIIF factors CTD- <br /> make direct contacts different classes activators (8).                                                                                interacting mediator complex, including Srb proteins, <br /> second subclass coactivator Saccharomyces cerevisiae                                                                                Gal11p, Sug1p (32, 33, 60). identified additional mediator complex associated C-terminal <br />                                                                                factors interesting connections regulation gene <br /> domain (CTD) largest subunit RNA polymerase II <br />                                                                                expression (48, 60). report analysis (32, 33). Independently isolated different laboratories, mediator consists products SRB genes (sup-                   factors, Paf1p (RNA polymerase-associated factor 1). Using <br /> pressor RNA polymerase B), Gal11p, Sug1p, additional                    <span id='am-1' about='obo:IMR_0001700' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-2' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-3' property="oboInOwl:id" content="IMR:0001700" datatype="xsd:string"></span><span id='am-4' property="obo:IAO_0000115" content="The polypeptide that is not a gene product." datatype="xsd:string"></span><span id='am-5' property="rdfs:label" content="peptide" datatype="xsd:string"></span>peptide</span> sequence derived RNA polymerase- <br />                                                                                associated proteins, cloned PAF1 gene                                                                                disruption leads pleiotropic phenotypic traits includ- <br />    * Corresponding author. Mailing address: Department Biochem-             ing slow growth, temperature sensitivity, enlarged cells. <br /> istry, Biophysics Genetics, University Colorado Health Sciences         Consistent role transcription, localized <br /> Center, Box B121, 4200 East Ninth Ave., Denver, 80262. Phone:               Paf1p yeast cell nucleus. basis analysis (303) 270-3004. Fax: (303) 270-3326.                                           expression yeast genes PAF1 mutant cells,  <br />                                                                          669 <br />  670       SHI ET AL.                                                                                                                               MOL. CELL. BIOL. <br />  <br />  <br /> postulate Paf1p act cofactor important tran-                        2708C. pellets resuspended solution (48C) containing 18% Ficoll, <br /> scriptional activation repression diverse promoters.                         50 mM Tris-acetate (pH 7.9), 0.1 M potassium acetate, 1 mM PMSF. Nuclei <br />                                                                                       isolated centrifuging suspension 3,000 3 g 5 min. super- combination mutations PAF1 GAL11 leads                               natants decanted recentrifuged uniform white color. <br /> severe growth defects consistent possibility                      Nuclei recovered supernatant centrifugation 25,000 3 g factors involved duplication essential communication                        1 h. nuclear pellet resuspended TNE (10 mM Tris-HCl [pH 7.9], 1 <br /> functions regulatory factors RNA polymerase II.                           mM EDTA, 0.1 M NaCl) 0.3 ml g cells. suspension, 4 M <br />                                                                                       ammonium sulfate (pH 7.9) added, stirring, final concentration                                                                                       0.9 M. suspension stirred additional 30 min 48C. Insoluble <br />                     MATERIALS METHODS                                             protein removed centrifugation 35,000 rpm SW-40 rotor (Beck- <br />                                                                                       man) 48C. Supernatant protein (soluble nuclear fraction) precipitated    Strains media. S. cerevisiae strains used study YJJ453        addition dry ammonium sulfate (0.35 g ml), collected centrifuga- <br /> (MATa/MATa leu2D1/leu2D1 his3D200/his3D200 ura3-52/ura3-52), YJJ564                   tion, resuspended minimal volume TNE, frozen, stored 2708C. <br /> (MATa leu2D1 his3D200 ura3-52 gal11D::LEU2), YJJ662 (MATa leu2D1                      Protein concentrations measured using reagents Bio-Rad. his3D200 ura3-52), YJJ664 (MATa leu2D1 ura3-52 his3D200 paf1D::HIS3),                 Western blot (immunoblot) analysis, 300 mg protein spheroplasts, 200 mg <br /> YJJ699 (MATa leu2D1 gal11D::LEU2 ura3-52 his3D200 paf1D::HIS3), YJJ575                protein cytoplasmic fraction, 50 mg protein nuclear <br /> (MATa leu2D1 his3D200 ura3-52), YJJ577 (MATa leu2D1 his3D200 ura3-52              fraction separated sodium dodecyl sulfate-polyacrylamide gel electro- <br /> paf1D::HIS3). strains derived homozygous diploid              phoresis (SDS-PAGE) (10% polyacrylamide) (22). Affinity-purified anti-Paf1p <br /> YJJ453 (58) isogenic. Yeast strains grown YPD            antibody used detect immobilized Paf1p (22). <br /> synthetic medium prepared standard methods (21).                                      Genomic DNA analysis. Yeast strain YJJ453 grown YPD medium    Isolation PAF1 gene. Isolation Paf1p sequencing peptides     mid-log phase, DNA isolated 1.5 ml glass bead method (16). described previously (60). peptide sequences obtained: QEY-          Genomic DNA digested overnight appropriate restriction enzymes, <br /> IAPI AADTPETS. BLAST search (1) indicated peptides               electrophoresed 1% agarose gel, transferred nitrocellulose membrane, perfect match open reading frame chromosome II. following         cross-linked UV light, probed PAF1 PCR product prepared PCR primers designed amplify PAF1 coding sequence yeast          random priming (47). <br /> genomic DNA: 59ATCGCGGATCCATGTCCAAAAAACAGGAATATATTG                                      Yeast mRNA analysis. Total yeast RNA isolated described previously <br /> C39 59ATCGCGGATCCCTATTCTTCTTGTAAAGTTTCC39. prim-                             (16). galactose induction experiment, cells grown synthetic <br /> ers flanked BamHI site (underlined) extra bases facilitate cloning.   glucose dropout medium mid-log phase, pelleted, resuspended syn- <br />    Deletion disruption PAF1. step gene replacement method (44)         thetic galactose dropout medium (2% galactose). RNA samples quanti- used disrupt PAF1. novel PCR-based strategy used make               tated measuring optical density 260 nm, equal amounts RNA disruption construct entire coding sequence PAF1 deleted.           run 1% agarose-<span id='am-45' about='obo:IMR_0200017' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-46' property="oboInOwl:hasDbXref" content="KEGG:C00067" datatype="xsd:string"></span><span id='am-47' property="oboInOwl:id" content="IMR:0200017" datatype="xsd:string"></span><span id='am-48' property="rdfs:label" content="Formaldehyde" datatype="xsd:string"></span><span id='am-49' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>formaldehyde</span> gels, RNA blots prepared flanking sequences PAF1 amplified PCR. 59-flanking sequence         standard methods (47). probes prepared random priming. PAF1 amplified primers P1 (59CTTAGCACAACTGAATTCGA                        probes SalI fragment pJJ58  detect GAL7 GAL10 <br /> AAGG39) P2 (59ATCGCGGATCCGTGACCCTTTATACTATTATGAG                                  transcripts [2]), EcoRI-BamHI fragment pJJ157 (58)  detect ACT1 <br /> C39). 39-flanking sequence PAF1 amplified primers P3 (59CAT-          transcripts), PCR-amplified FUN38 pBluescript KS1 subclone 159 (6) ACCCGCTCGAGGAATATTGAGAAGTGAAGGGAGATTG39) P4 (59AT                                 using universal reverse sequencing primers, PCR-amplified MAK16 <br /> ACGAATGATGTTAATGGAGACTCCAGGATTGTCGACT39). BamHI                                   pBluescript KS1 subclone 162 (6) using reverse universal <br /> XhoI restriction sites added 59 ends P2 P3 (underlined),           sequencing primers. RNA blots quantitated PhosphorImager analysis. <br /> respectively. PCR products gel purified, cut BamHI XhoI,           b-Galactosidase assays. Reporter plasmids used b-galactosidase assays <br /> ligated XhoI-BamHI fragment HIS3 Sc2676 (52). ligated              previously described (19, 20). pLGSD5 contains 365-bp GAL10  <br /> products amplified PCR primers P1 P4, expected PCR           stream activating sequence (UAS) fragment; pSV14 GAL4 17-mer <br /> product (3 kb) used transform diploid yeast cells (YJJ453) (21).           binding site. 2mm plasmids indicated UAS elements inserted 59 <br /> diploid cells sporulated, tetrads dissected (21). Deletion       CYC1 TATA region transcription initiation site. Plasmids trans- <br /> entire coding sequence PAF1 confirmed Southern blot analysis (47).          formed strains YJJ662 YJJ664 standard methods (21). Growth <br />    Preparation anti-Paf1p antibody. Paf1p produced recombinant            induction transformants described Northern (RNA) <br /> protein PCR amplification PAF1 coding sequence total yeast             blot analyses <span id='am-50' about='obo:IMR_0200234' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-51' property="oboInOwl:id" content="IMR:0200234" datatype="xsd:string"></span><span id='am-52' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-53' property="rdfs:label" content="Uracil" datatype="xsd:string"></span><span id='am-54' property="oboInOwl:hasDbXref" content="KEGG:C00106" datatype="xsd:string"></span>uracil</span> omitted selection plasmids. DNA using 59TCCATATGTCCAAAAAACAGGAATATA39 59GCCG                               induction galactose allowed proceed 5 h. Extract preparation GATCCTTATTCTTCTTGTAAAGTTTCC39 primers. underlined se-                          b-galactosidase assays performed described previously (38). <br /> quences NdeI BamHI sites included subsequent cloning steps;          Construction gal11 paf1 double mutant. Strain YJJ564 crossed PCR product cleaved restriction enzymes, gel purified, ligated     YJJ577, diploids selected plates lacking uracil leucine. pET11a (Novagen) cut enzymes (47). resulting plasmid         diploid sporulated, tetrads dissected standard methods (21). <br /> used transform Escherichia coli BL21(DE3), Paf1p produced                 vitro transcription. preparation yeast cell transcription ex- <br /> partially purified transformed strain previously described (62).      tracts transcription reaction conditions described previously (69). micrograms insoluble suspension Paf1p mixed              G cassette transcription templates lacking (pJJ460) containing UASHSE <br /> equal volume Titer Max Adjuvant (Vaxcel ) used raise antibodies         (pJJ468) used (69). reaction mixture contained 5 mg WCE protein rabbits (22). resulting antibody affinity purified using Paf1p puri-    ml 10 mg template ml. Transcription reactions  <br /> fied chromatography Mono Q (Pharmacia HR5/5) (63). Purified Paf1p           formed 26, 33, 378C. Labeled transcripts isolated, resolved, visual- <br /> coupled Affi-Gel 10 (Bio-Rad) according manufacturer&#226;&#8364;&#8482;s instructions.        ized, quantitated described previously (69). anti-Paf1p antiserum applied column, washed solution <br /> containing 20 mM HEPES (N-2-hydroxylethylpiperazine-N9-2-ethanesulfonic <br /> acid) (pH 7.9), 150 mM NaCl, 1 mM EDTA eluted 0.1 M <span id='am-21' about='obo:IMR_0100118' typeof='owl:Thing obo:IMR_0000967 obo:IMR_0000947 obo:IMR_0000965 obo:IMR_0001695 obo:IMR_0000001 obo:IMR_0100116'><span id='am-22' property="oboInOwl:hasExactSynonym" content="Gly" datatype="xsd:string"></span><span id='am-23' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-24' property="oboInOwl:hasExactSynonym" content="Glycine" datatype="xsd:string"></span><span id='am-25' property="oboInOwl:id" content="IMR:0100118" datatype="xsd:string"></span><span id='am-26' property="rdfs:label" content="Aminoacetic acid" datatype="xsd:string"></span><span id='am-27' property="oboInOwl:hasDbXref" content="KEGG:C00037" datatype="xsd:string"></span><span id='am-28' property="oboInOwl:hasAlternativeId" content="IMR:0200057" datatype="xsd:string"></span><span id='am-29' property="rdfs:label" content="Gly" datatype="xsd:string"></span><span id='am-30' property="rdfs:label" content="Glycine" datatype="xsd:string"></span><span id='am-31' property="oboInOwl:hasExactSynonym" content="Aminoacetic acid" datatype="xsd:string"></span><span id='am-32' property="rdfs:label" content="glycine" datatype="xsd:string"></span>glycine</span>                                                RESULTS <br /> (pH 2.5). milliliter fractions collected tubes containing 200 ml 1.0 M HEPES, pH 7.9. Peak fractions determined spectrophotometrically,              Cloning sequence analysis yeast PAF1 gene. pooled, dialyzed column wash buffer. <br />    Subcellular localization Paf1p. Yeast strain YJJ575 grown YPD <br />                                                                                       isolated RNA polymerase-associated proteins using medium (21) 308C A600 1. Cells harvested centrifugation,          monoclonal antibody directed CTD capture  <br /> washed water, resuspended 0.1 M Tris-SO4 (pH 9.3) containing 10           sociated factors transcriptionally active cell ex- <br /> mM dithiothreitol (0.1 0.3 g cells ml buffer), gently shaken      tract (60). peptide sequences obtained room temperature 20 min. Cells collected, washed spheroplast- <br /> ing buffer (1.2 M sorbitol, 20 mM potassium phosphate; pH 7.4), resus- <br />                                                                                       RNA polymerase-associated protein apparent molec- <br /> pended spheroplasting buffer 0.1 g cells ml. Yeast lytic enzyme (ICN     ular mass 65 kDa: QEYIAPI AADTPETS (60). Biochemicals) added (7.5 mg enzyme g cells), resulting          genes encoding peptides exactly match open read- <br /> suspension shaken gently 308C 80 90% yeast cells          ing frame identified yeast genome sequencing project <br /> spheroplasts. progress spheroplasting reaction monitored diluting aliquots suspension 9 volumes water checking lysis <br />                                                                                       (Fig. 1). sequence encodes novel gene resides light microscopy. resulting spheroplasts washed times            right arm chromosome II known RIF1 spheroplasting buffer resuspended MIB buffer (0.6 M mannitol, 20 mM            SNF5 genes. sequence PAF1 (polymerase- <br /> HEPES [pH 7.4], 1 mM phenylmethylsulfonyl fluoride [PMSF]) 0.5 g cells          associated factor) gene, predict protein 445 amino ml. Cells subsequently lysed precooled Dounce homogenizer 20 strokes using B pestle diluted twofold MIB buffer.                                                                                       acids calculated molecular mass 49 kDa (Fig. 1), <br /> resulting suspension centrifuged 5 min 3,000 3 g (48C). Super-        lacking significant homology sequence current <br /> natants spin cytoplasmic fraction frozen stored     database. protein sequence encoded PAF1  VOL. 16, 1996                                                            Paf1p, YEAST RNA POLYMERASE II-ASSOCIATED FACTOR                                     671 <br />  <br />  <br />  <br />  <br />                                                                                         FIG. 2. Paf1p nuclear protein. Cellular fractionation performed                                                                                      obtain cytoplasmic nuclear fractions described Materials Methods. <br />                                                                                      Protein samples (300 mg protein spheroplasts, 200 mg protein <br />                                                                                      cytoplasmic fraction, 50 mg protein nuclear fraction) <br />                                                                                      subjected SDS-PAGE (10% polyacrylamide) analyzed poly- <br />                                                                                      clonal antibodies Paf1p, Sup35p, TBP, described Materials    FIG. 1. Deduced <span id='am-14' about='obo:IMR_0001695' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-15' property="rdfs:label" content="amino acid" datatype="xsd:string"></span><span id='am-16' property="obo:IAO_0000115" content="Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins." datatype="xsd:string"></span><span id='am-17' property="oboInOwl:hasDbXref" content="CHEBI:33709" datatype="xsd:string"></span><span id='am-18' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-19' property="oboInOwl:id" content="IMR:0001695" datatype="xsd:string"></span><span id='am-20' property="oboInOwl:hasDbXref" content="MeSH:D000596" datatype="xsd:string"></span>amino acid</span> sequence Paf1p. PAF1 gene encoded            Methods. open reading frame YBR2016 right arm chromosome II (25). sequenced peptides used identify gene (QEYIAPI AADTPETS) positions 5 11 419 426. charged amino acids (negative [D E] positive [R K]) underlined. putative PEST sequence            letion confirmed genomic DNA analysis (data (amino acids 25 49) potential bipartite nuclear localization motif (amino   shown), diploid sporulated, tetrads dissected <br /> acids 119 141) underlined twice. <br />                                                                                      (21). 308C, intact tetrads exhibited pattern large <br />                                                                                      His2 small His1 colonies (Fig. 3B). Genomic DNA <br />                                                                                      analysis confirmed deletion PAF1 His1 spores interesting features. particular, Paf1p highly charged; 40%                    His2 spores (Fig. 3C). Complete rescue paf1 null amino acids charged residues (D, E, R, K),                     mutant centromere plasmid containing PAF1 gene <br /> net charge pH 7 223. carboxyl terminus protein                      demonstrated observed phenotypic traits result extremely acidic, glutamic aspartic acid represent-                      loss Paf1p function effects dis- <br /> ing 40 80 residues. high charge density explain                      rupting flanking genes (data shown). Consistent discrepancy calculated apparent molecular                            small size paf1 colonies, doubling time paf1 <br /> masses (49 versus 65 kDa). Paf1p contains potential bipartite                      mutant strain increased 3 4 h 2-h generation <br /> nuclear localization signal (Fig. 1, amino acids 119 141) (13)                    time isogenic wild-type strain (Fig. 4A). Disruption potential casein kinase phosphorylation sites (14).                      PAF1 resulted temperature-sensitive phenotype 36 amino terminus Paf1p contains potential PEST se-                            388C (Fig. 4B). paf1 cells cold sensi- <br /> quence (Fig. 1, amino acids 25 49) (43), signifies                    tive, grow slowly 14 258C cells rapid turnover proteins vivo (43). Analysis yeast RNA                       isogenic PAF1 strain. paf1 mutant cells abnormal genomic DNA indicated PAF1 transcribed                            morphology; cells enlarged   threefold larger <br /> single RNA species 1.6 kb single-copy gene (data                       wild-type cells) rounded (Fig. 4C). <br /> shown).                                                                                 expression levels yeast genes affected    Paf1p nuclear protein. produced recombinant                             paf1 mutation. Paf1p important transcription form Paf1p, material used elicit antibodies.                      yeast genes, transcript abundance temperature- <br /> Affinity-purified antibodies used probe fractions                        sensitive null mutation altered subsets genes RNA polymerase II affinity chromatography (60).                          permissive restrictive temperatures. confirmed Paf1p present anti-CTD eluate                          screened 20 yeast transcription units control column fractions (data shown). addition,                       transcripts begin fulfill prediction. analyzed antibody failed detect cross-reacting material                        transcription patterns shift nonpermissive tem- <br /> correct size cell extract paf1D strain (data                       perature. Cells grown permissive temperature, shown). determine intracellular location Paf1p,                        308C, shifted 388C, samples isolated fractionated lysed spheroplasts cytoplasmic nu-                          RNA analysis. paf1 cells 1 2 clear fractions resolved proteins gel electrophoresis.                    doublings 388C, growth observed 5 h <br /> Using anti-Paf1p antibody probe immobilized pro-                          shift nonpermissive temperature. tran- <br /> teins, Paf1p detected nu-                         scripts monitored 5 h shift, including clear fraction (Fig. 2). controls cell fractionation,                    ACT1, EGD1, DED1, CDC73, SPT15, unaffected TBP, general transcription factor (72),                          paf1 mutation (data shown). did observe  exclusively nuclear fraction, Sup35p, known                       threefold-lower abundance transcript EGD2 associated ribosomes (12), detected                       gene (49) paf1 strain 1 h shift cytoplasmic fraction. results indicate Paf1p                         nonpermissive temperature (data shown). Consistent nuclear protein, consistent identification RNA                        results, differential display analysis (35), abundance polymerase II-associated protein presence nuclear                       approximately 95% transcripts altered localization signal.                                                                 paf1 mutant, abundance remaining 5%    Pleiotropic phenotypic traits paf1 deletion-disruption                     transcripts increased decreased significantly (48). <br /> mutant. determine possible functions Paf1p, dis-                               paf1 mutation impairs induction galactose-induc- <br /> rupted PAF1 gene homozygous diploid yeast strain,                           ible genes. paf1 mutant strain exhibited slow growth deleting entire coding sequence replacing                          carbon sources tested, including glycerol galactose. HIS3 marker (Fig. 3A; Materials Methods).                             slow growth carbon sources observed  672      SHI ET AL.                                                                                                                           MOL. CELL. BIOL. <br />  <br />  <br />  <br />  <br />    FIG. 3. Disruption PAF1 S. cerevisiae.   Schematic representation PCR-based disruption strategy. 59- 39-flanking sequences PAF1 amplified yeast genomic DNA PCR (Materials Methods). Restriction sites BamHI XhoI, absent flanking sequences, added primers <br /> P2 P3 facilitate ligation HIS3 BamHI-XhoI fragment (52). resulting ligation product (PAF1 59-flanking sequence&#226;&#8364;&#8220;HIS3&#226;&#8364;&#8220;PAF1 39-flanking sequence) amplified PCR primers P1 P4. amplified fragment used transform diploid yeast strain YJJ453. (B) Tetrad analysis paf1 <br /> deletion-disruption mutant. heterozygous paf1/PAF1 disruption strain sporulated, tetrads dissected. dissected asci shown. (C) Confirmation paf1 disruption. Genomic DNA prepared spores tetrad, digested PstI, resolved 1% agarose gel. hybridization probe random-primed PCR product 39-flanking sequence PAF1, shown panel  <br />  <br />  <br />  <br />  <br /> strains mutations genes important induction                      genes affected paf1 mutant; example, galactose-regulated genes (29), analyzed effect                       4.8-kb transcript FUN38 gene, shown Fig. 5C. <br /> paf1 mutation galactose induction. Wild-type isogenic                         RNA level MAK16 gene dramati- <br /> paf1 mutant strains grown mid-log phase glu-                         cally higher paf1 mutant   eightfold) cose-containing synthetic medium shifted galactose-                          wild-type strain (Fig. 5C). MAK16 essential gene S. <br /> containing medium, samples collected RNA anal-                         cerevisiae (66), amino acid sequence encoded ysis (Fig. 5A). GAL7 GAL10 mRNAs                               MAK16 similar casein kinases (6). induced paf1 mutant, transcript levels signif-                    exact function MAK16 known, gene probably <br /> icantly lower   fivefold) wild-type                      involved cell cycle control, temperature-sensitive <br /> strain (Fig. 5A). confirm result alter-                     mutant MAK16 causes cells arrest G1 phase ations transcription, introduced reporter plasmids                        restrictive temperature (65). addition, mutations MAK16 <br /> taining UAS galactose-regulated promoter (UASGAL),                       result loss M1 double-stranded RNA virus-like par- wild-type paf1 mutant strains. shown Fig. 5B,                    ticles S. cerevisiae (66). <br /> b-galactosidase activity UASGAL-lacZ fusion                            Paf1p required transcription model promoter <br /> duced  sixfold paf1 mutant, comparable                        vitro. test possible involvement Paf1p transcrip- <br /> reduction seen Northern blot analysis. mutations                        tion vitro, cell transcription extracts prepared genes affect induction galactose-regulated genes                     parallel wild-type isogenic paf1 mutant strains. (29), phenotype conferred paf1 mutation                         shown Fig. 6, basal transcription CYC1 core pro- <br /> secondary effect slow growth. isogenic cdc73 mutant                           moter (lacking UAS [UAS2]) G cassette template, <br /> strain, slowly growing temperature sensitive (42, 48),                     activated transcription similar template containing defect galactose induction (48). reduced galac-                       heat shock transcription factor-responsive UASHSE, tose induction does appear changes                     ratios transcription templates wild-type expression GAL4, paf1 mutation obvious                          mutant extracts essentially indistinguishable effect level GAL4 mRNA (68). results strongly                       temperatures tested. lack obvious defect consistent <br /> suggest alteration UASGAL-driven expression seen                        results vivo experiments demonstrating paf1 strain occurs transcriptional level                      mutation Paf1p affects expression small subset Gal4p general transcription apparatus.                                      promoters; model templates used experiment    Paf1p negatively regulates MAK16 gene expression. iden-                       appropriate reveal Paf1p function. <br /> tify additional transcriptional defects paf1 mutant,                         Synthetic phenotype gal11 paf1 double mutant. <br /> surveyed transcripts 17 genes 42-kb segment                            Gal11p, component RNA polymerase II holoenzyme <br /> chromosome (4). RNA levels                            (33), postulated play role communicating  VOL. 16, 1996                                              Paf1p, YEAST RNA POLYMERASE II-ASSOCIATED FACTOR                                    673 <br />  <br />  <br />  <br />  <br />                                                                          FIG. 4. Pleiotropic phenotypes paf1 mutant.   Growth curves                                                                       wild-type strain paf1 deletion-disruption strain. Wild-type (YJJ575)                                                                       paf1 mutant (YJJ576) strains grown YPD medium 308C. growth <br />                                                                       curves shown plotted log scale. (B) Temperature-sensitive phenotype                                                                       paf1 mutant. Wild-type (YJJ575) paf1 mutant (YJJ576) strains                                                                       grown YPD plates 388C. (C) Altered cell morphology caused paf1 <br />                                                                       mutation. wild-type (YJJ575) paf1 mutant (YJJ576) strains grown <br />                                                                       YPD medium mid-log phase 308C photographed                                                                       magnification. mutant cells enlarged rounded. <br />  <br />  <br />  <br />  <br /> RNA polymerase upstream activators repressors (3,             II-associated factor, nuclear localization Paf1p, 24, 39, 46, 53). phenotype conferred gal11 mutation       pleiotropic phenotype conferred null allele PAF1, similar paf1 resulting  fivefold reduction   identification positive negative effects expression galactose-regulated genes (53)            apparently unrelated genes support hypothesis Paf1p <br /> increased decreased transcript abundance                general transcription factor mediator subset yeast genes (17, 39). determine RNA poly-             yeast genes. Paf1p joins growing list yeast transcriptional <br /> merase II-associated factors functioned pathway        regulators positive negative roles gene tran- nonoverlapping pathways, constructed gal11 paf1 dou-          scription. regulators include Rap1p (Grf1p Tuf1p [5, <br /> ble mutant. Gal11p Paf1p function pathway,         26, 50, 51]), Mcm1p (Prtf Grm [5, 31]), Gal11p (Spt13p [17, phenotype double mutant severe             53]), Sin4p (Tsf1p [9, 10, 27, 28]), Sin3p (Rpd1p Gam2p [59, phenotype single mutant.                63, 71]), Spt16p (Cdc68p [37]), Reb1p (Grf2p [7, 64]), Gal11p Paf1p function distinct pathways,        Rgr1p (27). feature common factors promoter- <br /> partially functionally redundant, expect se-          specific function, negative effects certain promoters <br /> vere phenotype double mutant. constructed           positive effects  general mechanisms gal11 deletion mutation (gal11D::LEU2) strain isogenic        invoked explain functions genes. used disruption paf1 observed              involves interaction chromatin; mechanism previously seen yeast strains (53), mutation       suggested Sin4p (27, 28) Spt16p (37, 45, 70). impaired galactose induction  fivefold displayed       mechanism envisions direct interaction basal tran- <br /> modest growth defect YPD medium (data shown).               scriptional machinery. regard, Gal11p encodes com- <br /> used strain create GAL11/gal11 PAF1/paf1 heterozy-          ponent RNA polymerase II holoenzyme (32). iso- <br /> gous diploid sporulated, 15 tetrads          lation Paf1p RNA polymerase-associated factor dissected described Materials Methods.             link closely second proposed mechanism, al- <br /> tetrads showed 2 His1:2 His2 2 Leu1:2 Leu2 segre-             reason assume mechanisms gation pattern.  double gal11D::LEU2 paf1D::HIS3          mutually exclusive. <br /> mutants grew slowly 308C (doubling time .8 h)            striking feature PAF1 coding sequence highly single mutants (Fig. 7). Like paf1 mutant,     charged acidic nature. negative charge double mutant inviable elevated temperatures.          localized carboxyl terminus. High charge content severe growth defect double mutant indicates Paf1p        acidity common features transcription factors (30). Gal11p function distinct pathways,     example, products SPT genes, includ- required normal yeast cell growth.                       ing Spt5p (56), Spt6p (55), Spt7p (18), Spt8p (15), Spt16p <br />                                                                       (Cdc68p) (45) encode acidic proteins. proteins <br />                          DISCUSSION                                   encoded SPT6, -8, -16 genes extremely <br />                                                                       acidic N C termini, feature shared Paf1p. products <br />   work identified novel factor, Paf1p,        SPT genes, affect transcription subset appears involved expression subset yeast         yeast promoters, PAF1 product define new <br /> genes. identification protein RNA polymerase         family promoter-specific transcription factors. <br />  674       SHI ET AL.                                                                                                                           MOL. CELL. BIOL. <br />  <br />  <br />  <br />  <br />                                                                                        FIG. 6. Paf1p required transcription model template vitro. <br />                                                                                     Preparation cell transcription extracts vitro transcription                                                                                     G cassette templates described Materials Methods. Transcription <br />                                                                                     reactions performed 26, 33, 378C indicated. white bars <br />                                                                                     indicate transcripts basal template lacking UAS (UAS2), black <br />                                                                                     bars transcripts template containing UASHSE activated                                                                                     heat shock transcription factor transcription extract (69).                                                                                     figure ratios incorporation templates containing <br />                                                                                     UASHSE templates lacking UAS (UAS2) calculated scanning                                                                                     indicated bands autoradiogram densitometer. <br />  <br />  <br />  <br />                                                                                     possible connection MAK16 remain investi- <br />                                                                                     gated. requirement functional Paf1p high tempera- <br />                                                                                     tures decreased expression uni- <br />                                                                                     dentified essential gene, seen EGD2 transcript,                                                                                     altered ratios expression multiple genes products <br />                                                                                     dependent precise stoichiometries correct function. <br />                                                                                        Srb protein-containing mediator complex S. <span id='am-55' about='obo:IMR_0100177' typeof='obo:IMR_0100022 owl:Thing obo:IMR_0000947 obo:IMR_0001359 obo:IMR_0000001 obo:IMR_0001362'><span id='am-56' property="oboInOwl:hasExactSynonym" content="C2-ceramide" datatype="xsd:string"></span><span id='am-57' property="rdfs:label" content="N-Acylsphingosine" datatype="xsd:string"></span><span id='am-58' property="rdfs:label" content="ceramide" datatype="xsd:string"></span><span id='am-59' property="oboInOwl:id" content="IMR:0100177" datatype="xsd:string"></span><span id='am-60' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-61' property="oboInOwl:hasExactSynonym" content="N-Acylsphingosine" datatype="xsd:string"></span><span id='am-62' property="oboInOwl:hasExactSynonym" content="cer" datatype="xsd:string"></span><span id='am-63' property="rdfs:label" content="C2-ceramide" datatype="xsd:string"></span><span id='am-64' property="rdfs:label" content="cer" datatype="xsd:string"></span><span id='am-65' property="oboInOwl:hasDbXref" content="KEGG:C00195" datatype="xsd:string"></span>cer</span>- <br />                                                                                     evisiae shown mediate transcriptional response                                                                                     activators vitro vivo (32, 33). Recently,                                                                                     genes encoding components mediator, SRB10                                                                                     SRB11, cloned (36). Srb10p Srb11p involved <br />                                                                                     transcriptional activation (34, 36) tran- <br />    FIG. 5. paf1 mutation causes altered transcription vivo.   paf1 <br /> mutation reduces induction GAL gene transcripts. Wild-type (YJJ662)                                                                                     scriptional repression specific genes cells <br /> paf1 mutant (YJJ664) strains grown synthetic medium containing glu-         (61) yeast genes response glucose (34). <br /> cose, pelleted, resuspended synthetic medium containing 2% galactose.     component mediator, Gal11p, indicated times, aliquots cells frozen 2708C RNA pre-        positive negative regulatory roles transcription (17, 46). <br /> pared fractionated described Materials Methods. hybridiza- <br /> tion GAL7-GAL10 probe, blot stripped rehybridized                                                                                     isolation Paf1p defines fourth RNA polymerase II- ACT1 probe internal control. (B) paf1 mutation reduces induction       associated factor positive negative effects UASGAL reporter construct. b-galactosidase assays performed        transcription. Paf1p unlikely component  <br /> described Materials Methods. indicated reporter plasmid,         diator complex basis strategy used isola- independent clones assayed, experiment repeated times. Mean values presented. Standard errors typically                                                                                     tion. Immobilization largest RNA polymerase II subunit 25% reported value. Units activity obtained fol-       antibody directed CTD shown <br /> lowing formula: (optical density 420 nm 3 1,000)/(milliliters assayed 3 time     exclude interaction mediator RNA <br />  minutes] 3 protein concentration  milligrams milliliter]). (C)       polymerase II (23, 32). initial fraction RNA poly- <br /> MAK16 transcript elevated paf1 mutant. Wild-type (YJJ575) paf1 <br /> mutant (YJJ576) strains grown YPD medium, RNA prepared <br />                                                                                     merase-associated factors included Paf1p did  analyzed outlined panels B. probes prepared         tain mediator factors (60). addition, using tagged random priming PCR-amplified MAK16 DNA FUN38 DNA (4) (gen- <br /> erous gifts D. Kaback). <br />  <br />  <br />  <br />  <br />    pleiotropic phenotypic traits paf1 mutant suggest Paf1p global transcriptional regulator. consis- <br /> tent identification functionally unrelated <br /> targets Paf1p, including GAL genes, EGD2, MAK16. <br /> MAK16 (maintenance killer) originally identified genes necessary maintaining L double- <br /> stranded RNA virus killer toxin-encoding satellite, M1 S. cerevisiae (66). MAK16 essential viability; temper- <br /> ature-sensitive mutant causes G1 cell cycle arrest large <br /> unbudded cells terminal phenotype (65, 66). termi- <br /> nal morphology paf1 mutant cells arrested 388C                              FIG. 7. Synthetic growth defect gal11 paf1 double mutant. Isogenic <br /> showed high percentage large, unbudded cells (data                         wild-type (YJJ575), paf1 (YJJ576), gal11 (YJJ564), gal11 paf1 (YJJ699) <br /> shown), functional significance observation                    strains streaked YPD plate grown 308C 3 days. <br />  VOL. 16, 1996                                                           Paf1p, YEAST RNA POLYMERASE II-ASSOCIATED FACTOR                                        675 <br />  <br />  <br /> version Paf1p, identified complexes containing Paf1p                         MAK16-SPO7 region. J. Bacteriol. 176:1872&#226;&#8364;&#8220;1880. RNA polymerase II contain Srb proteins                           5. Bender, , G. F. J. Sprague. 1987. MAT a1 protein, yeast transcription <br />                                                                                         activator, binds synergistically second protein set cell-type- <br /> (49). Paf1p potentially interacts directly indirectly                      specific genes. Cell 50:681&#226;&#8364;&#8220;691. region(s) RNA polymerase II CTD.                            6. Bussey, H., D. B. Kaback, W.-W. Zhong, D. T. Vo, M. W. Clark, N. Fortin, <br />    increasingly clear gene-specific factors (activators                      J. Hall, B. F. F. Ouellette, T. Keng,  B. Barton, Y. Su, C. J. Davies, repressors) utilize multiple pathways communicate                             R. K. Storms. 1995. <span id='am-6' about='obo:IMR_0001349' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001698'><span id='am-7' property="oboInOwl:id" content="IMR:0001349" datatype="xsd:string"></span><span id='am-8' property="oboInOwl:hasDbXref" content="CHEBI:25608" datatype="xsd:string"></span><span id='am-9' property="oboInOwl:hasExactSynonym" content="nucleoside phosphate" datatype="xsd:string"></span><span id='am-10' property="rdfs:label" content="nucleotide" datatype="xsd:string"></span><span id='am-11' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-12' property="obo:IAO_0000115" content="A nucleotide consists of a nitrogen-containing base, a five-carbon sugar, and one or more phosphate groups. Nucleotides can carry chemical energy (e.g. ATP), form coenzymes (e.g. CoA), be used as specific signaling molecules (e.g. cAMP) in the cell. Nucleotides are the subunits of the nucleic acids. " datatype="xsd:string"></span><span id='am-13' property="rdfs:label" content="nucleoside phosphate" datatype="xsd:string"></span>nucleotide</span> sequence chromosome Sac- <br />                                                                                         charomyces cerevisiae. Proc. Natl. Acad. Sci. USA 92:3809&#226;&#8364;&#8220;3813. basal transcription apparatus. fact, artificial                      7. Chasman, D. , N. F. Lue,  R. Buchman, J. W. LaPointe, Y. Lorch, creation interaction DNA-binding factor                             R. D. Kornberg. 1990. yeast protein influences chromatin struc- <br /> Gal11p mediator complex sufficient trigger activa-                         ture UASg functions powerful auxiliary gene activator. Genes <br /> tion transcription (3). naturally occurring activators                       Dev. 4:503&#226;&#8364;&#8220;514. <br />                                                                                      8. Chen, J.-L., L. D. Attardi, C. P. Verrijzer, K. Yokomori, R. Tjian. 1994. <br /> repressors, different pathways connecting factors                        Assembly recombinant TFIID reveals differential coactivator require- <br /> transcription apparatus totally independent function-                         ments distinct transcriptional activators. Cell 79:93&#226;&#8364;&#8220;105. <br /> ally redundant. possible interpretation severe pheno-                       9. Chen, S., R. W. West, Jr., S. L. Johnson, H. Gans, B. Kruger, J. Ma. <br /> type paf1 gal11 double mutant reflects                            1993. TSF3, global regulatory protein silences transcription yeast <br />                                                                                         GAL genes, mediates repression a2 repressor identical consequence destruction different partially com-                          SIN4. Mol. Cell. Biol. 13:831&#226;&#8364;&#8220;840. <br /> pensatory pathways communication RNA polymerase                             10. Chen, S. C., R. W. West, Jr., J. Ma, S. L. Johnson, H. Gans, G. <br /> II. Regulatory proteins like Gal4p require Paf1p                           Woldehawariat. 1993. TSF1 TSF6, required silencing Saccharomy- <br /> Gal11p levels activation repression. ab-                          ces cerevisiae GAL genes, global regulatory genes. Genetics 134:701&#226;&#8364;&#8220;716. <br />                                                                                     11. Conaway, R. C., J. W. Conaway. 1993. General initiation factors sence RNA polymerase-associated factor, regulation                            RNA polymerase II. Annu. Rev. Biochem. 62:161&#226;&#8364;&#8220;190. reduced occurs; factors missing, cell                    12. Didichenko, S. , M. D. Ter-Avanesyan, V. N. Smirnov. 1991. Ribo- <br /> growth severely impaired.                                                            bound EF-1a-like protein yeast Saccharomyces cerevisiae. Eur. J. <br />    yeast transcription factors originally identified                          Biochem. 198:705&#226;&#8364;&#8220;711. <br />                                                                                     13. Earnshaw, W. C. 1987. Anionic regions nuclear proteins. J. Cell Biol. <br /> genetically. Paf1p RNA polymerase II-associated                             105:1479&#226;&#8364;&#8220;1482. <br /> factor, Cdc73p (42), identified biochemical screen                     14. Edelman,  M., D. K. Blumenthal, E. G. Krebs. 1987. Protein serine/ <br /> factors associated RNA polymerase II (48, 60).                             threonine kinases. Annu. Rev. Biochem. 56:567&#226;&#8364;&#8220;613. similarities differences altered patterns                       15. Eisenmann, D. M., C. Chapon, S. M. Roberts, C. Dollard, F. Winston. <br />                                                                                         1994. Saccharomyces cerevisiae SPT8 gene encodes acidic protein <br /> transcription isogenic strains bearing disruptions                         functionally related SPT3 TATA-binding protein. Genetics <br /> PAF1 CDC73 (48). mutations lead increased                                 137:647&#226;&#8364;&#8220;657. <br /> abundance MAK16 DBP2 transcripts (Fig. 5C [48]);                             16. Elder, R. T., E. Y. Loh, R. W. Davis. 1983. RNA yeast trans-  unlike gal11 paf1 defects, cdc73 mutation                          posable element Ty1 ends direct repeats, structure similar <br />                                                                                         retrovirus RNA. Proc. Natl. Acad. Sci. USA 80:2432&#226;&#8364;&#8220;2436. effect galactose induction. contrast severe                     17. Fassler, J. S., F. Winston. 1989. Saccharomyces cerevisiae SPT13/ <br /> phenotype conferred gal11 paf1 double mutation,                              GAL11 gene positive negative regulatory roles transcription. <br /> phenotype conferred cdc73 paf1 mutation resembles                             Mol. Cell. Biol. 9:5602&#226;&#8364;&#8220;5609. <br /> conferred paf1 single mutation (48).                      18. Gansheroff, L. J., C. Dollard, P. Tan, F. Winston. 1995. Saccharo- <br />                                                                                         myces cerevisiae SPT7 gene encodes acidic protein important phenotype conferred cdc73 gal11 double mutation                           transcription vivo. Genetics 139:523&#226;&#8364;&#8220;536. similar conferred cdc73 single mutation (48).                     19. Giniger, E., S. M. Varnum, M. Ptashne. 1985. Specific DNA binding facts consistent possibility Paf1p                          GAL4, positive regulatory protein yeast. Cell 40:767&#226;&#8364;&#8220;774. <br /> Cdc73p distinct functions single novel pathway                         20. Guarente, L., R. R. Yocum, P. Gifford. 1982. GAL10-CYC1 hybrid <br />                                                                                         yeast promoter identifies GAL4 regulatory region upstream site. <br /> communication RNA polymerase II. support                                Proc. Natl. Acad. Sci. USA 79:7410&#226;&#8364;&#8220;7414. <br /> idea, complexes contain RNA poly-                               21. Guthrie, C., G. R. Fink (ed.). 1991. Guide yeast genetics molec- <br /> merase II Paf1p Cdc73p (48). charac-                               ular biology. Methods Enzymol. 194:3&#226;&#8364;&#8220;37. <br /> terization PAF1, CDC73, genes encoding                           22. Harlow, E., D. Lane. 1988. Antibodies: laboratory manual. Cold Spring <br />                                                                                         Harbor Laboratory, Cold Spring Harbor, N.Y. <br /> polymerase-associated factors allow resolve role                   23. Hengartner, C. J., C. M. Thompson, J. Zhang, D. M. Chao, S.-M. Liao,  J. eukaryotic transcriptional regulation.                                               Koleske, S. Okamura, R.  Young. 1995. Association activator <br />                                                                                         RNA polymerase II holoenzyme. Genes Dev. 9:897&#226;&#8364;&#8220;910. <br />                                                                                     24. Himmelfarb, H. J., J. Pearlberg, D. H.  M. Ptashne. 1990. GAL11P: <br />                          ACKNOWLEDGMENTS                                                yeast mutation potentiates effect weak GAL4-derived activators. <br />                                                                                         Cell 63:1299&#226;&#8364;&#8220;1309. <br />    thank M. Woontner critical reading manuscript, <br />                                                                                     25. Holmstrom, K., T. Brandt, T. Kallesoe. 1994. sequence 32420 <br /> K. Gulyas assistance yeast genetic techniques, M. Ter-                     bp segment located right arm chromosome II Saccharomyces <br /> Avanesyan supplying anti-Sup35p antibodies. grateful S.                   cerevisiae. Yeast 10:s47&#226;&#8364;&#8220;s62. <br /> Fields suggestion analyze transcripts chromosome                26. Huet, J.,  Sentenac. 1987. TUF, yeast DNA-binding factor specific  D. Kaback supplying appropriate clones, F. Winston                 UASrpg upstream activating sequences: identification protein supplying lacZ reporter plasmids, T. Fukasawa supplying                    DNA-binding domain. Proc. Natl. Acad. Sci. USA 84:3648&#226;&#8364;&#8220;3652. <br /> GAL11 disruption construct.                                                         27. Jiang, Y. W., P. R. Dohrmann, D. J. Stillman. 1995. Genetic physical <br />    work supported National Institutes Health grant RO1                   interaction yeast RGR1 SIN4 chromatin organization GM38101 J J. F.B. supported Michigan State University                     transcriptional regulation. Genetics 140:47&#226;&#8364;&#8220;54. <br />                                                                                     28. Jiang, Y. W., D. J. Stillman. 1992. Involvement SIN4 global Michigan State University Agricultural Experiment Station. <br />                                                                                         transcriptional regulator chromatin structure Saccharomyces cerevi- <br />                                                                                         siae. Mol. Cell. Biol. 12:4503&#226;&#8364;&#8220;4514. <br />                                 REFERENCES                                          29. Johnston, M., M. Carlson. 1992. Regulation carbon phosphate <br />  1. Altschul, S. F., W. Gish, W. Miller, E. W. Myers, D. J. Lipman. 1990.           utilization, p. 193&#226;&#8364;&#8220;281. E. W. Jones, J. R. Pringle, J. R. Broach (ed.), <br />     Basic local alignment search tool. J. Mol. Biol. 215:403&#226;&#8364;&#8220;410.                       molecular cellular biology yeast Saccharomyces: gene expres- <br />  2. Baker, S. M., P. G. Okkema, J.  Jaehning. 1984. Expression             sion. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. <br />     Saccharomyces cerevisiae GAL7 gene autonomous plasmids. Mol. Cell.           30. Karlin, S. 1993. Unusual charge configurations transcription factors     Biol. 4:2062&#226;&#8364;&#8220;2071.                                                                  basic RNA polymerase II initiation complex. Proc. Natl. Acad. Sci. USA <br />  3. Barberis, , J. Pearlberg, N. Simkovich, S. Farrell, P. Reinagel, C. Bamdad,       90:5593&#226;&#8364;&#8220;5597. <br />     G. Sigal, M. Ptashne. 1995. Contact component polymerase      31. Keleher, C. , C. Goutte,  D. Johnson. 1988. yeast cell-type- <br />     II holoenzyme suffices gene activation. Cell 81:359&#226;&#8364;&#8220;368.                        specific repressor alpha 2 acts cooperatively non-cell-type-specific <br />  4. Barton,  B., D. B. Kaback. 1994. Molecular cloning chromosome            protein. Cell 53:927&#226;&#8364;&#8220;936. <br />     DNA Saccharomyces cerevisiae: analysis genes FUN38-          32. Kim, Y.-J., S. Bjorklund, Y. Li, M. H. Sayre, R. D. Kornberg. 1994.  676         SHI ET AL.                                                                                                                                MOL. CELL. BIOL. <br />  <br />  <br />       multiprotein mediator transcriptional activation interaction            yeast pet56-his3-ded1 gene region. Nucleic Acids Res. 13:8587&#226;&#8364;&#8220;8601. <br />       C-terminal domain RNA polymerase II. Cell 77:599&#226;&#8364;&#8220;608.                        53. Suzuki, Y., Y. Nogi,  Abe, T. Fukasawa. 1988. GAL11 protein, 33.   Koleske,  J., R.  Young. 1994. RNA polymerase II holoenzyme                  auxiliary transcription activator genes encoding galactose-metabolizing <br />       responsive activators. Nature (London) 368:466&#226;&#8364;&#8220;469.                                  enzymes Saccharomyces cerevisiae. Mol. Cell. Biol. 8:4991&#226;&#8364;&#8220;4999. <br /> 34.   Kuchin, S., P. Yeghiayan, M. Carlson. 1995. Cyclin-dependent protein            54. Swaffield, J. C., J. F. Bromberg, S.  Johnston. 1992. Alterations       kinase cyclin homologs SSN3 SSN8 contribute transcriptional                  yeast protein resembling HIV Tat-binding protein relieve requirement       control yeast. Proc. Natl. Acad. Sci. USA 92:4006&#226;&#8364;&#8220;4010.                              acidic activation domain GAL4. Nature (London) 357:698&#226;&#8364;&#8220;700. <br /> 35.   Liang, P.,  B. Pardee. 1992. Differential display eukaryotic messen-       55. Swanson, M. S., M. Carlson, F. Winston. 1990. SPT6, essential gene <br />       ger RNA means polymerase chain reaction. Science 257:967&#226;&#8364;&#8220;971.                 affects transcription Saccharomyces cerevisiae, encodes nuclear pro- <br /> 36.   Liao, S.-M., J. Zhang, D.  Jeffery,  J. Koleske, C. M. Thompson, D. M.              tein extremely acidic amino terminus. Mol. Cell. Biol. 10:4935&#226;&#8364;&#8220;4941. <br />       Chao, M. Viljoen, H. J. J. van Vuuren, R.  Young. 1995. kinase-             56. Swanson, M. S., E.  Malone, F. Winston. 1991. SPT5, essential gene <br />       cyclin pair RNA polymerase II holoenzyme. Nature (London) 374:                   important normal transcription Saccharomyces cerevisiae, encodes       193&#226;&#8364;&#8220;196.                                                                                acidic nuclear protein carboxy-terminal repeat. Mol. Cell. Biol. 11: <br /> 37.   Malone, E. , C. D. Clark,  Chiang, F. Winston. 1991. Mutations               3009&#226;&#8364;&#8220;3019. <br />       SPT16/CDC68 suppress cis- trans-acting mutations affect promoter           57. Tjian, R., T. Maniatis. 1994. Transcriptional activation: complex puz- <br />       function Saccharomyces cerevisiae. Mol. Cell. Biol. 11:5710&#226;&#8364;&#8220;5717.                    zle easy pieces. Cell 77:5&#226;&#8364;&#8220;8. <br /> 38.   Miller, J. H. 1972. Experiments molecular genetics. Cold Spring Harbor           58. Ulery, T. L., S.-H. Jang, J.  Jaehning. 1994. Glucose repression       Laboratory Press, Cold Spring Harbor, N.Y.                                              yeast mitochondrial transcription: kinetics derepression role nu- <br /> 39.   Nishizawa, M., Y. Suzuki, Y. Nogi, K. Matsumoto, T. Fukasawa. 1990.                 clear genes. Mol. Cell. Biol. 14:1160&#226;&#8364;&#8220;1170. <br />       Yeast Gal11 protein mediates transcriptional activation signal           59. Vidal, M., R. Strich, R. E. Esposito, R. F. Gaber. 1991. RPD1 (SIN3/ <br />       different transacting factors, Gal4 general regulatory factor repressor/          UME4) required maximal activation repression diverse yeast <br />       activator site binding protein 1/translation upstream factor. Proc. Natl. Acad.         genes. Mol. Cell. Biol. 11:6306&#226;&#8364;&#8220;6316. <br />       Sci. USA 87:5373&#226;&#8364;&#8220;5377.                                                              60. Wade, P. , W. Werel, R. C. Fentzke, N. E. Thompson, J. F. Leykam, R. R. <br /> 40.   Nonet, M. L., R.  Young. 1989. Intragenic extragenic suppressors              Burgess, J.  Jaehning,  F. Burton. novel collection accessory <br />       mutations heptapeptide repeat domain Saccharomyces cerevisiae              factors associated yeast RNA polymerase II. Submitted publication. <br />       RNA polymerase II. Genetics 123:715&#226;&#8364;&#8220;724.                                            61. Wahi, M.,  D. Johnson. 1995. Identification genes required a2 <br /> 41.   Peterson, C. L., J. W. Tamkun. 1995. SWI-SNF complex: chro-                   repression Saccharomyces cerevisiae. Genetics 140:79&#226;&#8364;&#8220;90. <br />       matin remodeling machine? Trends Biochem. Sci. 20:143&#226;&#8364;&#8220;146.                          62. Wang, B. Q., C. F. Kostrub,  Finkelstein,  F. Burton. 1993. Produc- <br /> 42.   Reed, S. , J. Ferguson, K. Y. Jahng. 1988. Isolation characteriza-            tion human RAP30 RAP74 bacterial cells. Protein Expr. Purif. <br />       tion genes encoding yeast mating pheromone signaling elements:                   4:207&#226;&#8364;&#8220;214. <br />       CDC72 CDC73. Cold Spring Harbor Symp. Quant. Biol. 53:621&#226;&#8364;&#8220;627. <br />                                                                                           63. Wang, H.,  Clark, P. R. Nic <br /> </body></html>